A Fluorescence‐Based High‐Throughput Screening Method for EGFR Inhibitors Using an EGFR‐Targeted Environment‐Sensitive Fluorescent Probe
- 1School of Modern Agriculture and Food Engineering Chuzhou University Chuzhou 239000 China chzu.edu.cn
- 2Key Laboratory of Pu-er Tea Science Yunnan Agricultural University Ministry of Education Kunming 650201 China meb.gov.tr
- 3College of Agronomy Chuxiong Normal University No.546 S Rd. Lucheng Chuxiong 675099 China cxtc.edu.cn
Abstract
Fluorescence technology offers a highly sensitive, rapid, and efficient approach for drug screening at the cellular level, enabling the direct quantification of drug‐target binding interactions through precise measurement of fluorescence intensity changes. In our previous research, a small‐molecule fluorescent probe targeting epidermal growth factor receptor (EGFR) was successfully developed, featuring strong targeting specificity, low background signal, and an “off–on” response feature. Based on the EGFR‐overexpressing A431 cell line, this study established a cell‐based screening system for EGFR inhibitors and successfully identified flavokawain A (FKA), a novel potential EGFR inhibitor. FKA notably reduces the expression levels of p‐EGFR and its downstream molecule p‐Erk in the EGFR signaling pathway. It demonstrates a potent inhibitory effect on the proliferation of A431 cells, effectively suppressing clone formation and cellular migration, and exhibits a strong apoptosis‐inducing effect against A431 cells. This fluorescence‐based high‐throughput screening method has demonstrated its effectiveness in identifying novel EGFR inhibitors from a wide range of natural materials. It holds significant application potential and plays a crucial role in expediting the discovery of EGFR inhibitors from medicinal sources.
Related
- A Fluorescent Nucleosome Platform for High-Throughput Sirtuin Kinetic Analysis and Inhibitor Discovery
- Pharmaceutical residues in food samples: occurrence, toxicity, fluorescence quenching mechanisms, and analysis using carbon dot-based fluorescent probes
- An effective fluoroquinolone-based fluorescent probe for ultrasensitive Zn2+ detection exhibiting “turn-on” fluorescence
- Near-infrared fluorescent probe-mediated high-throughput discovery of a natural β-galactosidase inhibitor for senescence-associated atherosclerosis therapy.
- Microscale high-throughput screening-assisted discovery of a photo/copper dual catalytic system for benzylic C(sp2)–C(sp3) Suzuki–Miyaura coupling: data mining and mechanistic insights
BibTeX
@article{wang2026fluorescencebased,
title = {{A Fluorescence‐Based High‐Throughput Screening Method for EGFR Inhibitors Using an EGFR‐Targeted Environment‐Sensitive Fluorescent Probe}},
author = {Li-Xia Wang and Xiang-Dan Cuan and Xian-Yun Chen and Xuan-Jun Wang},
journal = {Journal of Analytical Methods in Chemistry},
year = {2026},
month = nov,
doi = {10.1155/jamc/9333993},
url = {https://doi.org/10.1155/jamc/9333993},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - A Fluorescence‐Based High‐Throughput Screening Method for EGFR Inhibitors Using an EGFR‐Targeted Environment‐Sensitive Fluorescent Probe
AU - Li-Xia Wang
AU - Xiang-Dan Cuan
AU - Xian-Yun Chen
AU - Xuan-Jun Wang
PY - 2026
DA - 2026/11/03
JO - Journal of Analytical Methods in Chemistry
DO - 10.1155/jamc/9333993
UR - https://doi.org/10.1155/jamc/9333993
AB - Fluorescence technology offers a highly sensitive, rapid, and efficient approach for drug screening at the cellular level, enabling the direct quantification of drug‐target binding interactions through precise measurement of fluorescence intensity changes. In our previous research, a small‐molecule fluorescent probe targeting epidermal growth factor receptor (EGFR) was successfully developed, featuring strong targeting specificity, low background signal, and an “off–on” response feature. Based on the EGFR‐overexpressing A431 cell line, this study established a cell‐based screening system for EGFR inhibitors and successfully identified flavokawain A (FKA), a novel potential EGFR inhibitor. FKA notably reduces the expression levels of p‐EGFR and its downstream molecule p‐Erk in the EGFR signaling pathway. It demonstrates a potent inhibitory effect on the proliferation of A431 cells, effectively suppressing clone formation and cellular migration, and exhibits a strong apoptosis‐inducing effect against A431 cells. This fluorescence‐based high‐throughput screening method has demonstrated its effectiveness in identifying novel EGFR inhibitors from a wide range of natural materials. It holds significant application potential and plays a crucial role in expediting the discovery of EGFR inhibitors from medicinal sources.
SN - 2090-8865
SN - 2090-8873
ER -